parthenolide and Diabetes Mellitus, Adult-Onset

parthenolide has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hao, Q; Li, X; Liu, Q; Qiu, W; Wang, H; Wen, Y; Zhang, L; Zhang, W1
Datusalia, AK; Khare, P; Sharma, SS1

Other Studies

2 other study(ies) available for parthenolide and Diabetes Mellitus, Adult-Onset

ArticleYear
Inhibition of NF-κB Reduces Renal Inflammation and Expression of PEPCK in Type 2 Diabetic Mice.
    Inflammation, 2018, Volume: 41, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gluconeogenesis; Inflammation; Insulin Resistance; Kidney; Mice; NF-kappa B; Phosphoenolpyruvate Carboxykinase (GTP); Sesquiterpenes

2018
Parthenolide, an NF-κB Inhibitor Ameliorates Diabetes-Induced Behavioural Deficit, Neurotransmitter Imbalance and Neuroinflammation in Type 2 Diabetes Rat Model.
    Neuromolecular medicine, 2017, Volume: 19, Issue:1

    Topics: Acetylcholinesterase; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Brain Chemistry; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Exploratory Behavior; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Interleukin-6; Maze Learning; Neurotransmitter Agents; NF-kappa B; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Streptozocin; Tumor Necrosis Factor-alpha

2017